澳优︰因应市场变化积极调整渠道策略，坚守长期主义发展

4 7 月, 2022
HONG KONG, Jul 4, 2022 - (亚太商讯 via SEAPRWire.com) - 澳优乳业(1717.HK)昨晚刊发公告知会公司股东及潜在投资者，集团预期截至2022年6月30日止六个月的营收净利较去年同期有所下降。于2022年上半年，集团预期录得收入约人民币33.5亿元至人民币35.0亿元，同比减少18.0%至21.6%，而公司权益持有人应占利润则预期录得约人民币9,500万元至人民币1.6亿元，同比减少73.1%至84.0%。澳优解释利润减少主要由于集团因应市场变化，积极调整销售渠道叠加宏观因素导致自家品牌配方牛奶粉收入减少所致。2022年上半年，由于中国内地出生率下降及部分地区实行严格防疫措施，婴幼儿配方奶粉行业面临前所未有的挑战。根据AC尼尔森(AC Nielsen)数据显示，2022年1月至4月期间，行业整体销售额水平按年下降4.4%，销售量按年下降 6.2%，整体销售呈下行趋势。然而，得益于自身优质的产品质量及过往成功的品牌建设，从零售端层面，海普诺凯1897于2022年上半年销售份额保持持续稳健增长。根据同一市场研究数据显示，截至2022年4月30日止期间，海普诺凯1897的市场份额同比提升0.5个百分点，佳贝艾特整体营收表现依旧跑赢整个市场。集团自家牛奶粉自成立以来一直录得高速增长，过去五年的年复合增长率为34.1%，其中海普诺凯1897业务单元过去五年的年复合增长率更达61.7%。是次收入减少主要由于集团为向消费者提供更新鲜、更优质的产品，同时减少各大经销商及各渠道伙伴的库存压力所做出的一次主动调整。澳优自2021年底起，通过减慢向分销商分发自家牛奶粉，从而对分销渠道的整体存货水平实行更严格控制。此前公司对于自家品牌羊奶粉亦有过类似短期且一次性的主动分销渠道调整，结果显示调整过后的自家羊奶粉不论在渠道管理、与经销商合作及品牌力方面均更加坚韧及扎实。2021年，自家品牌羊奶粉(中国区)回归同比双位数增长。此外，是次业务调整预计将在今年度第三季度完成，随着渠道策略调整的推进及产品力、品牌力及服务力的全面提升，集团有信心海普诺凯1897在下半年有望全面回归预期的稳健增长。不谋全局者，不足谋一域；不谋万世者，不足谋一时。长久以来，澳优以长期发展的眼光看待企业成长，始终围绕消费者、渠道商需求开展商业活动，追求行业生态健康发展。集团相信，通过积极调整与部分经销商的合作，为合作伙伴减少库存压力，不仅将保障消费者权益，更将强化渠道商信心，为公司长远发展奠定基础，为股东带来更深远的回报。关于澳优乳业股份有限公司澳优乳业股份有限公司为一家生产设备主要设于荷兰、中国、澳洲及新西兰的婴幼儿配方奶粉及营养品公司。澳优于全球范围内从事生产、研发及销售婴幼儿奶粉、成人奶粉、其他乳制品及营养食品。旗下拥有多个著名婴幼儿配方粉，包括「佳贝艾特」、「澳优能立多」、「海普诺凯」等。澳优于中国的厂房为内地第一批成功取得生产许可证换证的厂房；于新政策下，澳优位于荷兰及澳洲的工厂亦为首批成功获发海外产品进口许可证的海外婴幼儿配方奶粉制造商之一。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
艾伯科技2021/22年度全年业绩转亏为盈 ACN Newswire

艾伯科技2021/22年度全年业绩转亏为盈

3 7 月, 2022
HONG KONG, Jul 3, 2022 - (亚太商讯 via SEAPRWire.com) - 艾伯科技股份有限公司（「艾伯科技」或「公司」，连同其附属公司统称「集团」；股份代号：2708.HK）欣然宣布截至2022年3月31日止年度（「本年度」或「年内」）的综合全年业绩。年内，受惠于主营业务的高速增长，集团得以扭亏为盈。艾伯科技致力提供优质的5G、信创及物联网一站式产品及解决方案，其三大主营业务分别为5G（通信设备及专网解决方案）、信息技术应用创新（「信创」）IT（终端 产品及行业解决方案）及物联网（产品及解决方案）。年内，受惠于经济活动复苏及客源有所扩大，集团业绩实现高速增长并转亏为盈，收益由去年同期人民币约5亿6,033万元大幅上升86.7%至人民币约10亿4,630万元。集团毛利上升53.9%至人民币约1亿7,860万元（2020/21年度：人民币约1亿1,602万元），而毛利率为17.1%，（2020/21年度：20.7%）。本年度公司拥有人应占溢利为人民币约1,466万元，而2020/21年度的公司拥有人应占亏损则约为人民币约4,210万元。本年度每股基本盈利为人民币约2.67分，而去年之每股基本亏损为人民币约9.81分。抓紧信创及产业数字化政策风口 推动业务增长从「十三五」到「十四五」，中央及地方政府一直以发展「数字经济」和建设「数字中国」为重要目标，明确「数字中国」建设战略，抢占数字经济产业链制高点。各级政府大力推进信创产业的发展，促进信创产业在多个领域落地生根，带动传统IT信息产业转型。随着中国信创产业规模呈现迅速增长，并渗透各个领域，关键核心技术也展开自主研发从而实现原创替代。中央和地方政府大力促进信创采购，锐意提升信创IT产品应用比例，并已开始进入重点行业市场如金融、电信、能源等行业，各级各领域加大对国产设备及软硬件的采购力度，市场规模扩大，反映国产替代已经进入到实质性阶段。集团乘「十四五」政策之东风，大力布局信创业务，按照营销模式划分为直销及原厂委托设计（「ODM」）赛道、积极参与自主招投标，加速推进产品落地，并获得广泛认可。智能终端产品销售业务和软件开发业务实现重大突破 逐步迈向收成期智能终端产品销售业务是集团的主要收入来源，占本年度总收益约85.2%。年内，集团致力开发、生产及向客户销售度身定制的物联网智能终端产品，当中包括优质的全国产化信创IT产品如笔记本电脑、平板计算机、一体机、台式机计算机、行业网关服务器等。受惠经济活动复苏及国家层面信创产业的利好政策推动，加上集团早前签订之信创IT产品订单陆续出货交付，带动智能终端产品销售业务收益大幅增长。集团年内的智能终端产品销售业务收益为人民币约8亿9,137万元，同比大幅增长约121.7%，成为年内集团收益增长幅度最大的业务。集团的软件开发业务是根据客户的业务及管理需求，为客户规划及设计软件系统框架及功能列表，提供定制的软件应用开发服务，该业务占总收益约10.0%。凭借强大的软件开发能力，集团多年来提供优质软件应用开发服务，服务不同行业客户。除与现有客户维持长期及策略性关系，集团同时亦积极开拓新客源，以扩大顾客基础并带动销售。年内，集团软件开发业务持续扩展，客源亦有所扩大，录得收入人民币约1亿423万元（2020/21年度：人民币约4,549万元），同比大幅增加约129.1%。系统集成业务方面，集团基于对客户需求的分析与评估，利用物联网及相关技术，为客户提供综合及定制系统解决方案。鉴于系统集成业务的收益来自单次性项目，收益相对其他分部业务浮动，集团于年内的收入收窄至人民币约3,982万元（2020/21年度：人民币约1亿100万元），占集团总收入3.8%。系统维护服务业务方面，集团提供信息系统的软件及硬件系统维护服务，服务范围包括系统设备维护及管理、数据库维护、系统日常监控及系统升级等。由于业务优化调整，集团于本年度的系统维护服务项目有所减少，收入轻微收窄至人民币约1,088万元（2021年度：人民币约1,183万元），占集团总收入1.0%。加快推进产品落地 乘政策东风促进业务规模成倍增长集团乘「十四五」政策之东风，大力布局信创业务，并积极参与自主招投标，加速推进产品落地。年内，由集团设计开发的纯国产化笔记本计算机正式走向市场，并获得了广泛认可。集团大力推动信创产业发展和产品研发，致力争取更多市场份额，所生产的纯国产化信创IT产品有望成为集团未来业绩之增长点。在不断完善产品的基础上，集团将投入资源加大信创IT产品的市场宣传推广力度，联合产业合作伙伴，全面推动集团信创IT产品落地销售，共同加快国产化替代在各行业的迅速普及推广。 作为行业领先的产业数字化解决方案企业，集团已与多间国有大型企业及民营企业达成项目合作，在5G专网领域获得了丰富的项目经验。未来，集团将在前期项目成功经验的基础上，凭借在行业的稳固基础及与合作企业在技术、供应链和市场等各方面产生的协同效应，组织开展5G行业专网研究和试点，打通从应用到部署等关键环节，为运营商和行业伙伴提供最优质的方案。艾伯科技主席兼执行董事黎子明先生表示：「集团三大业务板块在底层技术、应用技术、供应链、项目和业务模式等诸方面紧密相连、相互协同。我们把5G、信创IT和物联网技术进行融合创新，形成新的业务模式和产业生态，达到有效发挥自身优势和综合技术实力，实现整体价值创造的最大化产出的目的。此外，我们将积极物色能与现有主营业务产生强大协同效应的合适并购目标，以支持集团营运及快速发展。凭借集团技术上的积累，配合市场强劲的需求，集团三大业务可望产生巨大的协同效应，促进集团业务规模增长。展望未来，管理层将继续寻求突破，致力为投资者及股东缔造长远而稳定的回报。」关于艾伯科技股份有限公司艾伯科技股份有限公司（股份代号：2708.HK）是行业领先的产业数字化解决方案企业，专注在中国提供5G通信设备及专网解决方案、信创IT终端产品及行业解决方案、物联网产品及解决方案以及产业数字化解决方案，业务主要分为四个类型，包括（i）智能终端产品销售;（ii）系统集成;（iii）软件开发;及（iv）系统维护服务。集团深耕物联网领域超过二十年，客户来自中国公营及私营界别，如中央政府机构、大型国有企业及私营企业。如欲查询更多数据，请浏览艾伯科技股份有限公司网站：http://www.ibotech.hk Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
金力永磁荣获稀土永磁行业全球首张SGS PAS 2060碳中和达成宣告核证证书 ACN Newswire

金力永磁荣获稀土永磁行业全球首张SGS PAS 2060碳中和达成宣告核证证书

30 6 月, 2022
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 2022年6月30日中国领先的高性能稀土永磁材料生产商江西金力永磁科技股份有限公司（「金力永磁」或「公司」，连同其附属公司，统称「集团」；深交所股票代码︰300748/港交所股票代号：6680 ）欣然宣布，公司荣获稀土永磁行业全球首张由国际公认的测试、检验和认证机构SGS颁发的PAS 2060碳中和达成宣告核证证书。（「证书」）。双方于今日在赣州锦江国际酒店举行证书发布会，江西省赣州市人民政府副市长陈水连先生、SGS知识与管理服务事业群南区和中西区总监张秋妹女士、金力永磁董事长兼总经理蔡报贵先生等共同出席颁证仪式。金力永磁董事长兼总经理蔡报贵先生致欢迎辞。金力永磁董事长兼总经理蔡报贵先生及SGS知识与管理服务事业群南区和中西区总监 张秋妹女士进行颁证仪式。PAS 2060是国际公认的碳中和标准，要求企业在量化温室气体排放的基础上努力节排，实现低碳生产模式。就无法减省的碳排放量，PAS 2060亦鼓励企业自愿采取补偿和抵消方式实现碳中和。此次金力永磁荣获PAS 2060碳中和达成宣告核证证书，足证公司在「碳中和」方面所作出的努力已获国际权威机构的高度认可。公司已根据ISO 14064标准建立和实施对碳排放源的系统管理和盘查，并向SGS专业的审核团队展示出公司已达成认证范围内产品和服务所承诺的要求，以及具备组织方针目标的系统能力。同时，金力永磁亦承诺在实施减排方案的基础上，通过采取相关有效方式全部抵消剩余的碳排放。自成立以来，金力永磁一直致力践行绿色发展的理念，积极履行企业责任。公司通过向多家龙头企业提供稀土永磁材料，共同助力中国及世界各地实现碳中和目标。于2021年，公司新能源汽车驱动电机磁钢产品销售量可装配新能源乘用车约124万辆，每年助力减少碳排放量约256万吨；节能变频空调磁钢产品销售量可装配空调压缩机约4,850万台，每年助力减少碳排放量约1,755万吨；风电磁钢产品销售量可装配风力发电机的装机容量约8.65GW，每年助力减少碳排放量约 1,433万吨。综合上述三大关键下游领域，2021年金力永磁实现助力碳减排合共约3,444万吨。此外，金力永磁亦通过技术创新、精益生产、管理节能、工艺节能、效率提升、设备更新换代、转换绿色电力等各种节能方式减少自身碳排放。公司已与金风科技（002202.SZ; 02208.HK）合作开展绿色电力计划。公司亦公布了与华润电力（836.HK）设立在北方地区的管理公司华润电力投资有限公司北方分公司签订《战略合作框架协议》，以新能源项目开发建设为基础，于多个项目展开合作，包括保障性并网集中式新能源项目、工业园区可再生能源替代项目、火电灵活性改造配套新能源项目、分布式风电项目和永磁电机改造项目，继续以绿色电力推动了公司的低碳生产。展望未来，金力永磁已制定明确的减排目标，将通过增加绿色能源的使用并加强对原材料的回收利用，未来预计实现每年平均减少5%至10%的单位排放或能耗。在「成为世界稀土永磁行业领军企业」愿景的引领下，公司将继续加大产品创新及研发，进一步改善能源效率，大力开发和导入光伏电力，持续实现集团层面和产品层面的碳减排与碳中和，以切实行动真正实现「用稀土创造美好生活」的企业使命，助力中国及世界各地迈向碳中和。关于江西金力永磁科技股份有限公司江西金力永磁科技股份有限公司(「金力永磁」或「公司」；港交所股票代号：6680 / 深交所股票代号︰300748) 为新能源和节能环保领域中增长迅速的全球领先高性能稀土永磁材料生产商。2020年按高性能稀土永磁材料产量计及按使用晶界渗透技术生产高性能稀土永磁材料计，公司均位列世界第一。公司产品被广泛应用于新能源汽车及汽车零部件、节能变频空调、风力发电、3C、工业节能电机、节能电梯、轨道交通等领域，并与各领域国内外龙头企业建立了长期稳定的合作关系。于2022年1月14日，公司在香港联交所成功发行H股，成为首家全球高性能稀土永磁材料行业「A+H」上市公司，同时成功募集42.41亿港元。关于SGSSGS 是国际公认的测试、检验、认证机构，在全球拥有超过93,000名员工，分布在2,600多个分支机构和实验室，具有全球性的服务网络。SGS长期位列福布斯全球2000强，并连续六年入选道琼斯可持续发展指数及第三年入选富时社会责任指数。SGS通标标准技术服务有限公司由SGS集团和隶属于国家市场监督管理总局系统的中国标准科技集团共同于1991年成立，现已在全国建成了90多个分支机构和200多间实验室，拥有15,000多名训练有素的专业人员。在中国，SGS的服务能力已全面覆盖到纺织品及鞋类、玩具及婴幼儿用品、家居及轻工产品 、电子电气、农产食品、生命科学、化妆品及个人护理、石油化工、矿产、环境、工业、交通和电子商务等多个行业的供应链上下游。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

天齐锂业启动招股：全球最大的锂开采运营商 客户群稳定庞大

30 6 月, 2022
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 据彭博终端机报道，近年来，随着全球新能源汽车市场的迅速增长及储能产业的飞速发展，金属锂的市场需求趋于旺盛。6月30日，中国及全球领先的锂业龙头——天齐锂业开启港股招股，最高发售价为每股港82元，公司的上市进程更进一步。公开数据显示，天齐锂业是中国及全球领先的锂生产商，于2010年8月31日在深圳证券交易所上市（股份代号：002466）。公司通过子公司泰利森，持有格林布什矿场的锂矿开采权，运营涵盖锂价值链的关键环节，包括开采锂矿石并生产锂精矿及生产锂化合物及衍生物。持续加码在全球的业务布局 市场份额及市场地位不俗根据伍德麦肯兹报告（下同），天齐锂业是中国唯一通过大型、一致且稳定的锂精矿供给实现100%自给自足以及全面垂直整合锂矿的锂生产商。按2021年的锂精矿产量计，公司的一家子公司为全球最大的锂开采运营商，市场份额为38%，且按2021年锂产生的收入计，公司排名第三。按2021年的产量计，公司亦为全球第四大及亚洲第二大锂化合物生产商，市场份额分别为7%及12%。众所周知，锂电池是电动汽车的重要组成部分，天齐锂业具备丰富的产品组合，结合先进的生产能力，能够制造出锂化合物及衍生物，以满足主要电池材料制造商的严格要求。公司的碳酸锂产品被认为是中国市场的标杆产品，是2021年世界第二大电池级碳酸锂供货商及世界前十大电池级氢氧化锂供货商之一。为进一步扩大产能，天齐锂业持续加码在全球业务布局。公司在西澳洲奎纳纳建造了一个电池级氢氧化锂制造厂，一期工厂年产能为24,000吨，施工已完成且目前正处于试生产阶段。同时，公司正就奎纳纳电池级氢氧化锂二期工厂的建设计划进行可行性研究及编制所需资本开支估算，并且在四川省遂宁市建设碳酸锂工厂，而建成投产后预计年产能分别可再增加24,000吨和20,000吨。凭借在优质锂原料自给自足的能力、多样化的产品组合以及领先的生产能力，天齐锂业能够满足电动汽车和储能领域日益增长的需求，并跟上锂基新能源领域的最新技术突破的步伐，进而推动公司的稳步发展。优质的上游锂资源提供强劲支持 拥有业内显著成本优势除了锂电方面，天齐锂业还是世界上少数几个同时拥有高质量硬岩锂矿和锂卤水矿的企业之一。通过泰利森的锂矿开采权，公司可使用格林布什矿场，按产量及储量计算，该矿场拥有世界最大的硬岩锂矿。泰利森于2021年的化学级锂精矿产量达102.0千吨LCE，使其成为全球最大的化学级锂精矿供货商。与此同时，天齐锂业通过对SQM持股，在战略上获得阿塔卡马盐湖的资源。阿塔卡玛盐湖于2021年为世界上最大的卤水制锂储地。按产量计算，SQM亦是2021年世界上最大的卤水锂化合物生产商。对SQM的战略持股增加了公司对SQM世界一流的卤水资源的布局，从而进一步巩固公司的行业地位，并产生稳定且具吸引力的长期财务回报。同时，凭借庞大优质的上游锂资源提供强劲支持，天齐锂业能够为锂化合物生产提供充足、稳定的原材料。在业务覆盖方面，得益于业务线之间的协同作用，天齐锂业的营运涵盖锂行业价值链的关键环节和方面，包括开采锂矿石及生产锂精矿、生产锂化合物及衍生物，能够有效应对不断变化的市场需求。天齐锂业是中国唯一通过大型、一致且稳定的锂精矿供给实现了100%自给自足并全面垂直整合的生产商。100%锂精矿自给自足，可实现具有一致性和高质量的各种终端产品的规模化生产及先进的生产技术，高度先进的生产技术为其提供成本优势，从而提高营运效率、安全性和盈利能力。客户群稳定、优质且庞大 盈利能力及核心竞争力增强作为全球锂行业的老牌领先企业，天齐锂业已建立稳定的优质客户群，主要包括全球顶级电池制造商、电池材料生产商、跨国电子公司和玻璃生产商。按2021年市场份额计，公司的产品供应给世界五大大型锂离子电池制造商中的三家制造商，以及世界十大正极材料制造商中的六家。天齐锂业凭借全面垂直整合的业务模式，能够取得显著的成本优势以及高盈利的能力。根据招股书，于2019年、2020年及2021年12月31日止年度，公司的收益分别为人民币4,816.4百万元、人民币3,215.2百万元及人民币7,597.9百万元。截至2021年12月31日止年度，公司录得净利润人民币4,205.8百万元。此外，在锂矿开采和生产方面，天齐锂业拥有长期且经证实的高效的营运往绩，凭借专业知识和过硬的技术实力，能够为电池行业供应链实现认证过程所要求的产品高度一致性和高质量，对市场准入构成了若干高壁垒。强大敬业的研发团队 发展空间有望进一步提升在研发方面，天齐锂业组建一个敬业的研发团队，其核心领导团队成员为来自对锂产品的研发至关重要的各类科学领域的经验丰富的专家。截至最后实际可行日期，公司合共166项专利获得授权，32项专利正处于申请阶段，包括若干行业领先的技术及产品创新。中长期来看，随着全球能源结构的调整以及满足「碳中和」的要求，储能系统将成为未来十年锂行业增长最快的终端市场之一。根据伍德麦肯兹报告，储能相关基础设施的锂消耗量预计自2022年至2026年以11.6%的复合年增长率增长，于2026年达59.0千吨LCE消耗量。成功的业务模式，显著的成本优势，领先的技术及庞大优质的客户群，均助力着天齐锂业长期受益行业高速发展带来的机遇。在港上市后，公司的行业地位有望进一步上升，市场份额不断扩大，具备更大的想象空间，值得期待。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
EC Healthcare and Yoho Group Form Strategic Partnership ACN Newswire

EC Healthcare and Yoho Group Form Strategic Partnership

30 6 月, 2022
HONG KONG, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for strategic collaboration. The partnership will be focused on accelerating the growth of medical, aesthetic medical and beauty and wellness services in the e-commerce market, and jointly boosting the e-commerce penetration of medical, aesthetic medical and beauty and wellness services in Hong Kong. The partnership will strengthen ECH's online presence in Hong Kong and expand its customer base and further consolidate the leading market position.Under the collaboration, (i) The Group will become Yoho Group's anchor merchant in beauty and healthcare services and Yoho Group will launch an online medical, aesthetic medical and beauty and wellness service zone. The dedicated section will enable the Group to reach a greater public domain traffic flow from the e-commerce platform with strong client synergy in the healthcare and beauty sector;(ii)Both Parties will strengthen their co-marketing efforts to increase the overall sales volume and promote product cross-sell; (iii) Both Parties agree to exchange know-how in precision marketing and consumer behavior analysis in healthcare and beauty sector, in order to develop more comprehensive digitalized marketing strategy to improve overall customer lifetime value; (iv) Both Parties will devote resources to jointly enhance technical solutions across social & mobile commerce, data-driven marketing, and fulfillment efficiency to streamline the entire consumer journey.Mr. Gemini Wong, Executive Director, Chief Digital Officer and Deputy Marketing Officer of EC Healthcare said, "The Group is delighted to establish a strategic partnership with Yoho Group. Through the collaboration, we hope to leverage Yoho Group's experience regarding online retail and the extensive reach to the accumulated customer traffic to boost the Group's e-commerce, diversify the digital marketing strategies and optimize the e-commerce experience so as to increase the overall sales volume, and raise the brand awareness and consolidate the leading position."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, focusing on preventive and precision medicine and leveraging investment in IT, brand, service and corporate culture to build a diversified enclosed healthcare ecosystem with the mission to bring health, beauty and happiness to everyone. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, a advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021About Yoho Group Holdings Limited Yoho Group Holdings Limited is one of the leading e-commerce platforms in Hong Kong, with more than 820,000 registered users as of the date of this announcement and over 2,290,000 monthly active users (based on the data in March 2022). According to Frost & Sullivan's data and the Group's revenue for the financial year ended 31 March 2021, the Group recorded the highest online retail sales among e-commerce players in consumer electronics and home appliances and acquired a market share of approximately 5.6%. Leveraging its vast customer base, the Group is expected to launch its online marketplace operations in the financial year ending 31 March 2023 to expand the product and service offerings for its customers. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
天大药业2022全年业绩 ACN Newswire

天大药业2022全年业绩

30 6 月, 2022
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 天大药业有限公司 (天大药业或本集团 ，股份代号 ：0455.HK) 欣然宣布截至2022年3月31日止全年业绩。报告期内，本集团整体业务取得较好发展，收入5亿1,000万港元，同比增长7.5% 。创新和研发工作稳步推进, 研发费用1,590万港元，同比增长34.7%。本集团财务状况稳健，于2022年3月31日现金和现金等价物为3亿3,400万港元，具充足财务资源支持业务发展。为庆祝本集团更名为「天大药业有限公司」10周年，董事会建议派发末期股息每股0.26港仙和特别股息每股0.56港仙，回馈股东长期的支持和信赖。位于珠海金湾的新研发及制药基地药物和医疗科技业务收入3亿9,610万港元，同比增长10.7%。药物和医疗科技业务重点关注产品和技术，积极引进、研发、倂购创新药、健康产品和医疗器械，聚焦心脑血管、妇儿、呼吸系统、肿瘤、康复等重点领域。本集团主要产品心脑血管用药托平®缬沙坦胶囊在中国市场同类产品中销量第一，凭借在国家第三批集中带量采购第一顺位中标，放量增长，扩大品牌影响力。通过销售团队和渠道的整合, 本集团药品尤其是儿科用药托恩®布洛芬混悬液和布洛芬混悬滴剂取得满意的销售增长。位于珠海金湾的新研发及制药基地已顺利投产，第一期投资金额4.3亿港元，配置进口和国产最新型自动化设备，立足创新发展，加快丰富产品线和提高产能，已成功签订5个CDMO/CMO合同，锐意成为一个高标准、高质量、高效能的医药健康产业基地。中医药业务收入1亿650万港元，同比减少4.9%。报告期首9个月，中医药业务实现较快增长，运用多种方式实现和药农、合作社、经销商、药企等伙伴的互惠合作，构建面向全国全球的中药材业务网络。未来，将以品种为中心，重点发展中药材国内外贸易，中药饮片、配方颗粒生产销售及配送业务，整合产业上下游优质资源。医疗和保健服务收入740万港元，同比增长57.4%。本集团稳健推进新型中医馆「天大馆」拓展，自建、加盟和并购并举，优先开拓粤港澳大湾区，兼顾全国全球布局。自2019年起先后在珠海、香港和悉尼三地不同的中医药管理法规下开馆，打造全球连锁运营模式, 其中珠海天大馆成为全球首家获ISO 9001:2015质量管理体系认证和Qualicert国际服务认证的中医馆。本集团关注民众健康及积极履行企业社会责任，在2022年初第五波新冠疫情袭击香港期间，本集团依托「云上天大馆」推出「天大馆全球中医云端科技抗疫平台」，开展「赠医施药 同心抗疫」公益大行动，为民众提供从预防、治疗到康复的全方位远程中医医疗服务，并推出新冠后遗症中医调理服务。国家「十四五」规划提出全面推进健康中国建设，把保障人民健康放在优先发展的战略位置，为人民提供全方位全生命期健康服务。本集团秉承「您的健康是天大的事！」这一使命，贯彻「以发展中医药产业为基础，发展创新药物和医疗科技，发展优质医疗和保健服务」战略，实施「3D+1S」重大举措 (业务拓展BD、研究开发R&D、投资发展ID、市场销售S)，联动并举，通过外部引进、研发、倂购等方式，不断丰富产品线和提高管线内研发项目的质量和数量，并在全球范围内洽寻前沿技术和产品以及优质项目，努力实现高质量发展，为守护人类健康做出更大贡献。有关天大药业有限公司天大药业有限公司(香港联交所上市公司，股份代号0455.HK)以发展中医药产业为基础，发展创新药物和医疗科技，发展优质医疗和保健服务，致力发展成为立足中国，辐射全球的领先医药企业。新闻查询天大药业有限公司投资者关系部电话：+852 2545 3313 电邮：ir@tianda.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
医思健康与友和集团建立战略合作伙伴关系 ACN Newswire

医思健康与友和集团建立战略合作伙伴关系

30 6 月, 2022
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团与友和集团控股有限公司（「友和集团」；香港联交所股份编号：2347）就拟建立战略合作伙伴关系签署谅解备忘录。双方将合作重点推进香港医疗，美学医疗及美容养生于电子商务领域的快速发展，携手推动香港医疗，美学医疗及美容养生电子商务渗透率的提升。此次合作将强化集团的线上业务，扩大集团可触达的客群，进一步巩固集团的市场领先地位。就此次合作，(i)集团将成为友和集团在美容及医疗健康服务领域的主要商户，友和集团将为集团开设医疗，美学医疗及美容养生线上服务产品专区。这一专区将有望帮助集团引入更多电商平台上的公域客户流量，并创造医疗及医美客户群与友和集团的协同效益；(ii)集团将与友和集团联手推动相关服务产品的线上营销活动以提升销售额，丰富产品组合及提升交叉销售；(iii)集团将与友和集团就精准营销及消费者行为分析方面的洞见进行合作，以发展更全面的数字营销策略，提高客户的生命周期价值；(iv)集团将携手友和集团共同发展电子商务科技，双方将投入资源提升社交电商及电子商务解决方案的技术水平，数据驱动的营销能力，满足客户需求的运营效率，以优化消费者体验。医思健康执行董事兼首席数码执行官及副市场营销官黄志昌先生总结：「集团很高兴能与友和集团达成战略合作。通过是次合作，集团希望相信通过借助友和集团在线上零售领域的经验和累积的丰富客户流量，帮助集团强化电商业务布局，以及深化数码营销策略，为客户带来更便捷的电子商务体验，以进一步推动销售增长，品牌知名度的提升，从而巩固集团的行业领先地位。」关于医思健康香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心，通过资讯科技，服务，品牌和文化的不断投入，搭建一个完善的多元大健康闭环生态，致力于让这个世界变得更健康、美丽、快乐。集团为恒生综合指数成份股及MSCI香港小型股指数。 集团目前直营的诊所／服务中心主要位于大湾区，提供一站式医疗及健康服务。服务涵盖面极广，旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN、专业健发中心发森及多元化多维度的医学服务包括：健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、普通科门诊未来医生、全港最大一站式痛症管理平台纽约脊骨物理治疗中心、全方位牙科服务中心庇利积臣牙科医务所，EC DENTAL CARE及恒健牙科医务所、高端影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心进汇医务中心，联汇专科，新医疗中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究关于友和集团控股有限公司友和集团控股有限公司为香港电子商务平台翘楚之一，于本公告日期的注册会员超过820,000人及每月活跃用户超过2,290,000名（按2022年3月数据计算）。根据弗若斯特沙利文的数据及本集团截至2021年3月31日止财政年度的收益，本集团在电子商务平台参与者中录得最高电子产品及家庭电器线上零售，市场占有率约为5.6%。凭借庞大的客户群，预期本集团于截至2023年3月31日止财政年度推出其线上平台业务，扩大为客户提供的产品及服务种类。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Jacobson Pharma Announces FY2022 Annual Results ACN Newswire

Jacobson Pharma Announces FY2022 Annual Results

30 6 月, 2022
HONG KONG, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period").KEY HIGHLIGHTS-- Year-on-year revenue up by 10.3%, amounting to HK$1,595.5 million -- Profit for the year up by 78.4%*, amounting to HK$187.7 million-- Strong growth witnessed on key therapeutic classes for chronic diseases such as lipid lowering agents and angiotensin II inhibitors -- Progress with expansion plan in Greater China as facilitated by Greater Bay Area ("GBA") healthcare policy and formation of joint venture with an established partner-- Delivery of approximately 9 million doses of Fosun BioNTech Comirnaty Vaccine in Hong Kong and Macau for the collaborative fight against COVID-19 During the Reporting Period, the Group delivered total revenue of HK$1,595.5 million with a year-on-year growth of 10.3%, primarily driven by the solid growth momentum of business in the public sector. The profit from operations and profit for the year was registered at HK$260.9 million and HK$187.7 million, representing a promising growth of about 48.9%* and 78.4%* respectively, as compared to the adjusted profit from operations* and adjusted profit* for the corresponding year of 2021. The Group's financial position remains stable as supported by a healthy cash flow, with adjusted earnings before interest, taxes, depreciation and amortisation (adjusted EBITDA) posted at HK$441.6 million for the Reporting Period and a net gearing ratio at 29.2% as of 31 March 2022. With a cash balance of HK$478.7 million as of the end of the Reporting Period, the Group also recently secured a syndicated loan of HK$1.4 billion to enhance its capital capability. The Board has recommended the payment of a final dividend of HK2.68 cents per share (FY2021: HK1.50 cents per share). Excluding the FY2021 special interim dividend in the form of distribution in specie of shares of JBM (Healthcare) Limited (Stock code: 2161.HK), an indirectly non-wholly owned subsidiary of the Company, total dividend for the Reporting Period amounts to HK3.88 cents per share (FY2021: HK2.30 cents per share), an increase of 68.7%.Solid Performance of Generics BusinessThe Group's generic drugs business demonstrated a resilient performance amidst the COVID-19 pandemic, presenting a solid growth of 13.6%, with revenue posted at HK$1,191.3 million for the Reporting Period. The Group's product offerings in the key therapeutic classes for chronic diseases such as diabetes and cardiovascular disease achieved high double-digit growth. For instance, the lipid-lowering product class recorded a strong growth of 37.2% in sales during the Reporting Period. In addition, the oncology drug class has also shown a significant growth of 572.6%, owing to the increased acceptance of the new Arsenic Trioxide Oral Solution.As a major supplier of essential medicines in Hong Kong, the Group responded swiftly to cater to the surged demand for medications during the fifth wave of the epidemic. This was reflected by the strong growth in the Group's analgesics (+18.6%), cough & cold preparations (+45.8%) and anti-inflammatory products (+77.5%). Steady Pipeline and Portfolio EnhancementThe Group continued to make steady progress with its research and development ("R&D") pipeline. As of 31 March 2022, the Group has a total of 172 products in the pipeline, among which 54 items have been approved for registration, 15 of them have been submitted for registration, 52 items have finished the development stage and are under stability preparation or stability study, plus 25 items are currently under formulation or pre-formulation research development stage.As a continuous drive for portfolio enhancement, the Group launched a number of new products during the Reporting Period, including Rabeprazole Tablets, Valsartan and Amlodipine Tablets, Telmisartan and Hydrochlorothiazide Tablets, Pregabalin Capsules, Atosiban Injection, and Idarubicin Injection. Additionally, the Group has secured the registration approvals for a group of new products such as Levetiracetam Tablets, Febuxostat Tablet, Dexmedetomidine Infusion, Pramipexole Extended Released Tablets, Brimonidine and Timolol Eye Drops, Telmisartan and Amlodipine Tablets for upcoming market launches. Tapping Specialty Drugs Market in China and AsiaFacilitated by new measures under the "Work Plan for Regulatory Innovation and Development of Pharmaceutical and Medical Devices in the Guangdong-Hong Kong-Macau Greater Bay Area", the Group has established collaboration with the University of Hong Kong-Shenzhen Hospital for the introduction of its Arsenic Trioxide Oral Solution (indicated for the treatment of acute promyelocytic leukaemia) into designated hospitals in the Greater Bay Area. The collaboration will also be part of a multi-centre clinical trial covering Guangdong, Singapore and Hong Kong. More recently, the Group, together with its non-wholly owned subsidiary, JBM (Healthcare) Limited (Stock code: 2161.HK), formed a joint venture with Ban Loong Holdings Limited (Stock code: 0030.HK), a company of which Yunnan Baiyao Group Co., Ltd (Stock code: 0538.SZ) is the controlling shareholder, to capture the growth opportunities of the specialty medicines in Greater China and the Asia-Pacific region. The joint venture will be primarily engaged in exploring business opportunities in various growth streams including specialty medicines (including orphan drugs), over-the-counter drugs, and branded healthcare products as well as medical devices in the Greater China region.Distribution of Fosun BioNTech Comirnaty Vaccine in Hong Kong and MacauThe Group is the exclusive distributor of Fosun BioNTech Comirnaty Vaccine (the "Vaccine") in Hong Kong and Macau. Up to the end of the Reporting Period, the Group delivered approximately 9 million doses of the Vaccine to the Department of Health and community vaccination centres in Hong Kong and the Macau governments. To protect the public against COVID-19 and help ensure herd immunity through vaccination, the Group is committed to supporting the governments and professional partners in the acceleration of vaccination in Hong Kong and Macau, especially among the elderly, and will continue to collaborate with the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its subsidiaries to supply booster vaccination doses for the public, as encouraged by the health authorities.Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, concluded, "While the pandemic continues to impact the market environment, the Group delivered a solid performance in FY2022 by focusing on strong execution, bolstered by our core capabilities and enhanced product pipeline and portfolio. We also take pride in playing a collaborative role in the distribution of the Fosun BioNTech Comirnaty Vaccine in Hong Kong and Macau and have demonstrated our commitment to robust manufacturing and logistics operations by ensuring a continuous supply of our essential medicines were delivered to hospitals and patients during Hong Kong's fifth wave of the epidemic."Looking ahead, we are entering 2022 with positive momentum as we aim to build a differentiated portfolio that anticipates future healthcare needs. By executing our R&D and in-licensing strategies, fostering strong partnerships, and cementing our foothold in key strategic markets, we will further diversify and transform our business, bringing sustainable growth and value to shareholders."About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 10 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.The Group aims at the continued strategic enrichment of its generic drug portfolios through the addition of high-value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan and Cambodia, forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com * Excluding the one-off Employment Support Scheme subsidy from the Hong Kong Government of about HK$81.1 million in FY2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
雅各臣公布二零二二财年全年业绩 ACN Newswire

雅各臣公布二零二二财年全年业绩

29 6 月, 2022
HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 （「 雅各臣 」或「 公司 」； 股份代号： 2633.HK )今天公布公司及其附属公司（统称「集团」）于截至二零二二年三月三十一日止年度（「二零二二财年」或「报告期」）的全年业绩。业绩亮点-- 收益按年增长10.3%至1,595.5百万港元-- 年内溢利增加78.4%*至187.7百万港元 -- 集团于其主要治疗类别业务取得强劲增长，例如降脂剂和血管紧张素II抑制剂等产品-- 大中华区扩展计划取得进展，受益于大湾区推出利好医疗保健政策，及与知名伙伴成立合资公司开拓市场-- 提供合共约9百万剂复星BioNTech复必泰疫苗给香港及澳门，共同抗击2019冠状病毒病疫情于报告期内，集团录得总收益1,595.5百万港元，按年增长10.3%，主要受公营界别业务稳健的增长势头推动。经营溢利及年内溢利则录得260.9百万港元及187.7百万港元，分别较二零二一年同期的经调整经营溢利*及经调整溢利*大幅增长48.9%*及78.4%*。集团财务状况维持稳健，现金流强劲。报告期录得扣除利息、税项、折旧及摊销前的经调整盈利(经调整EBITDA)441.6百万港元，截至二零二二年三月三十一日的净资本负债比率为29.2%。于报告期末，集团的现金余额为478.7百万港元，集团最近亦取得一笔14亿港元的银团贷款，有助进一步巩固资本实力。董事会建议宣派末期股息每股2.68港仙（二零二一年财年：每股1.50港仙）。不计及以实物分派形式分派公司间接非全资附属公司健倍苗苗（保健）有限公司（股份代号： 2161.HK ) 股份的二零二一年财年特别中期股息，报告期内的股息总额为每股3.88港仙（二零二一年财年：每股2.30港仙），较二零二一财年多派股息68.7%。 非专利药业务表现扎实报告期内，集团非专利药业务在疫情影响下仍然表现强韧，实现13.6%的稳健增长，收益为1,191.3百万港元。集团的产品于各个慢性疾病的主要治疗类别，包括糖尿病及心血管疾病等，均取得高双位数的增长。例如，降脂产品类别的销售于报告期内录得37.2%的增长。此外，由于公营界别对新药三氧化二砷口服液(Arsenic Trioxide Oral Solution)的接受性提高，肿瘤药物类别销售亦录得572.6%的大幅上升。 作为香港主要的基础药物供货商，集团迅速应对于第五波疫情期间激增的药物需求。镇痛剂(+18.6%)、咳嗽、感冒制剂(+45.8%)及抗炎产品(+77.5%)的强劲增长均反映相关药物的需求殷切。稳定加强产品管道及组合集团在持续推出新研发产品方面取得稳定进展。截至二零二二年三月三十一日，集团正在研发172项产品，其中54项已获准注册，15项已提交注册，52项已完成开发阶段并正进行稳定制备或稳定性研究，另有25项目前正进行配方研究或预制配方研究工作。为进一步丰富产品组合，集团于报告期内推出多项新产品，当中包括雷贝拉唑片(Rabeprazole Tablets) 、缬沙坦(Valsartan)及氨氯地平片(Amlodipine Tablets)、替米沙坦(Telmisartan)、及氢氯噻嗪片(Hydrochlorothiazide Tablets)、普瑞巴林胶囊(Pregabalin Capsules)、阿托西班注射剂(Atosiban Injection) 及埃达霉素注射剂(Idarubicin Injection)。此外，集团已就多项即将上市的新产品获得注册批准，例如左乙拉西坦片(Levetiracetam Tablets)、非布司他片(Febuxostat Tablet)、右美托咪定浸剂(Dexmedetomidine Infusion)、普拉克索缓释片剂(Pramipexole Extended Released Tablets)、酒石酸溴莫尼定及第莫洛滴眼液(Brimonidine and Timolol Eye Drops)、替米沙坦(Telmisartan)及氨氯地平片(Amlodipine Tablets)。拓展中国及亚洲专科药物市场在新推出的「粤港澳大湾区药品医疗器械监管创新发展工作方案」政策引导下，集团与香港大学深圳医院合作，计划将其用于治疗急性早幼粒细胞白血病的口服溶液－三氧化二砷口服液引入大湾区指定医院，这合作亦将作为覆盖广东、新加坡及香港的多中心临床试验的一部分。最近，集团连同其非全资附属公司健倍苗苗（保健）有限公司（股份代号：2161.HK）与万隆控股有限公司（股份代号：0030.HK），其控股股东为云南白药集团有限公司（证券代号0538.SZ），成立合资公司，以把握大中华区及亚太区专科药的增长机遇。该合资公司将主要在大中华区发掘专科药（包括罕见病用药）、非处方药、品牌医疗保健品及医疗器械的增长商机。在香港及澳门分销复星BioNTech复必泰疫苗集团为复星BioNTech 复必泰疫苗（「疫苗」）在香港及澳门的独家分销商。截至报告期末，集团已向香港的卫生署及小区疫苗接种中心及澳门政府提供合共约9百万剂疫苗。为了透过疫苗接种以对公众抵御2019冠状病毒病提供保护及实现群体免疫，集团致力与政府及专业伙伴合作，加快港澳地区特别是长者的疫苗接种率。在卫生部门的鼓励下，集团将继续与上海复星医药（集团）股份有限公司及其附属公司合作，为公众提供加强疫苗接种剂量。雅各臣主席及行政总裁岑广业先生总结 ：「虽然市场环境持续受疫情影响，对各种疾病患者的护理造成干扰，但凭借我们强大的核心业务能力、产品管线和组合，以强大的执行力带动集团于二零二二财年表现强劲。我们为在港澳分销复星BioNTech复必泰疫苗中担任协作角色深感自豪。本地爆发第五波疫情期间，我们致力维持稳健的制造及物流营运，以确保持续向医院及患者供应基础药物。展望未来，我们以良好的势头迈进二零二二年，目标是为打造可预见未来健康需要的独特产品组合。通过开展研发及引进授权策略、建立稳固的伙伴合作关系及于关键战略市场建立据点，我们将进一步推动业务多元化及转型，以实现持续增长，并为股东带来价值。」关于雅各臣科研制药有限公司（股份代号：2633）雅各臣是本地领先的医药公司，拥有垂直整合的业务，包括基础药物及专科药物的研发、生产、分销、销售及物流。作为本地主要的非专利药供货商，集团在香港私营及公营领域，具有最广泛的销售及分销的市场覆盖，并积极向策略性选择的亚洲市场伸延扩展。集团于香港设有10间PIC/S GMP认证的非专利药生产设施，并在各种治疗药物类别中拥有广泛的产品组合与享有优越市场地位。同时，集团一直致力透过增加各种高增值产品，策略性地扩大其非专利药的产品组合。扎根香港，集团已于中国、澳门、台湾及柬埔寨开设营运子公司，建立区域性商业平台，以把握亚太区及大中华地区的市场潜力。而自 2017 年 6月 1 日，集团获纳入 MSCI 香港微型股指数成份股。更多详情请浏览雅各臣科研制药有限公司网站：http://www.jacobsonpharma.com/* 不包括香港政府于二零二一财年发放的一次性保就业计划资助约81.1百万港元 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
达丰设备服务有限公司公布2022财年全年业绩 ACN Newswire

达丰设备服务有限公司公布2022财年全年业绩

29 6 月, 2022
HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - 达丰设备服务有限公司（「达丰」或「公司」，连同其附属公司统称「集团」）（股份代号：2153）为在中国成立的首家外资塔式起重机服务供货商，公布其截至2022年3月31日止年度（「2022财年」或「年内」）的全年业绩。2022财年，集团的收益为人民币867.0百万元，较截至2021年3月31日止年度增长9.3%，主要是由于自有及租赁塔式起重机的数量有所增加，而其中大部分起重机一直在现场作业并产生收益。集团的使用总吨米由2021财年的约2,491,629增加至2022财年的3,112,084。年内毛利减少约14.3%至人民币234.1百万元。年内溢利为人民币47.6百万元（2021财年：人民币101.2百万元）。溢利减少主要是由于受2022年3月向最高管理层提供股份奖励计划的会计处理（非现金调整）影响所致。董事会建议派发末期股息每股0.016港元。于2022年3月31日，集团有288个在建项目，未完成合约总值约人民币569百万元，手头项目共有42个，预期合约总值约人民币102百万元。其中，集团预期于截至2023年3月31日止年度完成总值约人民币497百万元的合约工程，显示来年将可录得高水平的盈利。达丰设备服务有限公司行政总裁邱国燊先生表示：「2022财年不仅对我们来说是艰难的一年，对于整个市场也是如此。尽管在疫情防控措施之下，疫苗接种率在各国开始上升，包括中国在内的经济体正在逐步复苏。但全球公共卫生、经济和就业仍受到2019新型冠状病毒病的不利影响。随着疫情在全球持续肆虐，全球市场在疫情下仍面对诸多不确定性。我们将藉此拓展新的市场机会，继续致力为客户提供一站式塔式起重机解决方案服务。」年内，集团通过增购塔式起重机及相关配套零件和部件，藉此扩大业务，以满足日益增长的客户需求。于本公布日期，集团管理合共1,180台塔式起重机，旨在迎合集团客户于中国各地的专业EPC项目。作为一家在中国享负盛名的外资塔式起重机服务供货商，集团在关注工人安全、服务质量及技术优势方面树立了良好声誉。集团目前持有77项与塔式起重机相关的实用新型及发明注册专利。除了提升制造能力外，集团亦持续提升塔式起重机及其附属结构件的再制造及再加工能力，并致力于透过开发数字化管理平台「iSmartCon爱建通」，以提供绿色服务，同时提高营运及管理效率。展望未来，集团将专注于中大型塔式起重机的经营，以满足日益增长的装配式建筑需求；并建立标准化的塔式起重机后市场服务生态系统，为打造绿色、安全及环保的塔式起重机服务产业奠定基础。达丰设备服务有限公司主席黄山忠先生总结:「未来，集团将在有效执行中国防控政策的同时，继续关注2019冠状病毒病疫情的发展，以确保员工安全，并减轻其对集团财务状况及经营业绩的负面影响。我们将继续巩固我们在市场上的优势和领先地位，以把握巨大的市场增长机会，推动可持续的长期业务，为股东带来满意的回报。」 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
中国万天公布全年业绩 ACN Newswire

中国万天公布全年业绩

28 6 月, 2022
HONG KONG, Jun 28, 2022 - (亚太商讯 via SEAPRWire.com) - 中国万天控股有限公司（「中国万天」，连同其附属公司统称「集团」；股份代号：01854.HK）宣布其截至2022年3月31日止年度（「本财政年度」或「回顾年内」）的经审核之全年业绩。中国万天董事局主席兼执行董事许国伟先生（左）和行政总裁兼执行董事钟学勇先生（右）为集团的中山分公司成立正式揭牌。回顾年内，中国万天继续在香港经营业务，主要从事采购、加工及食材供应，专注提供蔬菜及水果予香港餐饮服务经营商，目前已经向逾480家客户提供逾1,300种食材。受惠于香港政府放宽社交距离措施并推出2021年消费券计划，本地消费意欲有所改善；香港餐饮业气氛逐见明朗，订单数量随着餐饮业经营环境有所改善而录得增长，带动集团的收益在香港爆发第五波新冠肺炎前录得可观增长，全年总收益同比增加约19.7%至约127.7百万港元。毛利及毛利率分别为约18.7百万港元（2021年3月31日止年度：13.2百万港元）及14.6%（2021年3月31日止年度：12.4%）。然而，为配合集团未来发展和扩张，营运开支有所增加，当中包括集团于回顾年内有关全面收购所产生法律及专业费用，再者，回顾年内亦因应客户的信贷记录评估及当前市场条件而确认约5.4百万港元的预期信贷亏损拨备，以致年内亏损录得约11.0百万港元（2021年3月31日止年度：亏损8.2百万港元）。董事会不建议于本财政年度派发末期股息（2021年3月31日止年度：无）。于2022年5月，集团在深圳市南山区设立湾区总部，标志着中国万天正式进军潜力庞大的大湾区市场；同时集团宣布将加大力度发展生鲜供应、零售及餐饮和环保科技三大重点业务，把握市场机遇、积极提升品牌在大湾区的知名度，务求扩阔客户基础及市场占有率，以提升业务发展多元化及保持竞争力。 生鲜供应方面，集团将积极发挥原有香港供应链业务优势，把控采购需求、订单及交期、库存和收发货等环节，且提升各环节效率，实现以最快时间、最低成本，安全高效地将海产、肉类和蔬菜等生鲜食材送达客户手中。同时，集团将在香港累积的成功经验复制至大湾区市场，并积极在大湾区内物色潜在的业务伙伴及机遇以加快发展步伐，可望强强联合资源叠加，以把握大湾区市场的庞大需求，扩阔收入来源。另外，集团积极拓展包括零售及餐饮业务在内的下游业务。集团锐意把握大湾区零售及餐饮行业发展和机遇，未来在大湾区其他城市进一步扩大餐厅网络，拓展大湾区餐饮业务版图。凭借集团的上中下游全产业链优势开设更多主打生鲜食材的餐厅，逐步打造餐饮品牌「万天餐饮」。早前，集团在广东省中山市策略性开设两间主打生鲜食材的餐厅—「港式海鲜火锅店」和「韩国海鲜烧烤店」，集团将积极提升品牌在大湾区的知名度，务求扩阔客户基础及市场占有率。环保科技方面，集团积极配合国家「现代农业科技及绿色环保」的发展理念，将农业科技与绿色环保进一步结合，利用天台闲置空间，在屋顶缔造良田，增加城市绿化面积，一方面推广绿色都市让天下人吃上「放心菜」；另一方面推动绿色环保教育到大湾区内的企业及学校等机构，支持大湾区的可持续发展。集团继续多管齐下加快大湾区业务的发展步伐，继设立湾区总部后，集团的中山分公司亦于本月正式启业。2022年6月23日，集团的中山分公司成立典礼盛大举行，中国万天董事局主席兼执行董事许国伟先生及行政总裁兼执行董事钟学勇先生出席揭牌仪式。中山分公司的成立，意味着集团将广东省中山作为珠海、中山、江门的区域总部。集团亦相当看好广东省中山市的发展前景，锐意以广东省中山市作为三大重点业务的起始点，继而逐步将业务拓展至整个大湾区市场。展望未来，随着香港政府分阶段放宽限聚措施，本地餐饮营商环境大幅改善，集团预计香港业务将保持稳定发展，同时香港总部能以金融中心的角色全力协助，成为深圳总部的强力后盾。随着后疫情时代之到来，中国经济可望迅速复苏，大湾区业务对集团的重要性将逐渐增加，长远可望为集团带来稳定持续的收入，亦会成为集团业务的主要盈利增长点。去年12月，集团的中文和英文名称分别更改为「中国万天控股有限公司」和「China Wantian Holdings Limited反映集团之业务策略调整及积极更新企业形象，有利于集团的未来业务发展。集团管理层表示，大湾区作为中国开放程度最高、经济活力最强的区域之一，在国家发展大局中具有重要战略地位，加上拥有庞大的市场、独特的区位优势、开放的贸易环境和完善的产业结构等，造就前所未有的发展机遇。深圳总部的成立是集团迈向大湾区战略的第一步，后续集团将着眼于生鲜供应、零售及餐饮和环保科技三线业务发展，在大湾区建立上、中、下游全产业链，凭借独特的竞争优势提高市场占有率。管理层相信，三大业务策略可发挥强劲协同效应，创造独特优势，逐步打造大湾区绿色龙头品牌。关于中国万天控股有限公司中国万天控股有限公司（1854.HK）主要从事采购、加工及供应食材，专为香港餐饮服务经营商提供蔬菜及水果等业务。集团提供逾1,300种食材给逾480家客户。2022年5月，中国万天在深圳设立大湾区总部，标志着集团正式进军潜力庞大的大湾区市场，将发展零售及餐饮、上游现代农业及相关绿色环保推广三大重点业务，积极打造大湾区绿色龙头品牌，为客户提供新鲜健康食品，让天下人吃上放心菜。 有关更多资料，请浏览：chinawantian.etnet.com.hk Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
HKTDC launches brand-new exhibition model EXHIBITION+ ACN Newswire

HKTDC launches brand-new exhibition model EXHIBITION+

28 6 月, 2022
HONG KONG, Jun 28, 2022 - (ACN Newswire via SEAPRWire.com) - International trade fairs and sourcing modes have seen dramatic changes in the wake of the COVID-19 pandemic, with the organisers of many physical exhibitions and seminars taking a new digitised or hybrid path. To assist enterprises in adapting to the new normal, and help them stay closely connected to international buyers, the Hong Kong Trade Development Council (HKTDC) is launching the brand-new hybrid exhibition model EXHIBITION+ to strengthen its exhibition platform. Meanwhile, the HKTDC International Sourcing Show runs from 5 to 8 July at the Hong Kong Convention and Exhibition Centre (HKCEC). Exhibitors and buyers at the event will be among the first to enjoy the smart business-matching platform, Click2Match, to actively assist them in seizing business opportunities.HKTDC Deputy Executive Director Sophia Chong introduced the newly launched exhibition model EXHIBITION+ at a press briefing today, while Zuri Jewelry Company Ltd Director Victor Yiu (L) and Chit Tat Clock & Watch Co Ltd General Manager Philip Lau (R) shared their successful experiences using the Click2Match platform.The physical HKTDC International Sourcing Show will run at the Hong Kong Convention and Exhibition Centre from 5 to 8 July. Exhibitors and buyers can use the smart business-matching platform, Click2Match, from 5 to 15 July to connect with global buyers. The photo shows the 2021 HKTDC Lifestyle Sourcing Show.HKTDC Deputy Executive Director Sophia Chong said: "The pandemic has had a tremendous impact on Hong Kong's economy and particularly on small and medium-sized enterprises (SMEs). Amid the ongoing pandemic and geopolitical tensions, many enterprises have sought support from policies and aid packages to help them ride out the storm. From March 2020, the HKTDC adjusted quickly to the new reality, moving its various physical fairs, large-scale seminars and business-matching meetings to online platforms, striving to continue connecting local businesses with international buyers and offering various kinds of support. Now, the Council is launching EXHIBITION+ to help enterprises get better familiarised with digital platforms and capture online-to-offline international opportunities around the clock."More than 90% of buyers have used online sourcing platformsAccording to a recent buyer survey conducted by the HKTDC, which interviewed 600 international buyers from Association of Southeast Asian Nations (ASEAN) countries, Australia, Europe, Mainland China and the United States, most respondents (93%) had used online sourcing platforms, and over 85% had participated in virtual fairs to meet their sourcing needs. The majority of respondents said they would be willing to conduct sourcing through physical fairs (63%) or hybrid fairs (59%) once travel restrictions are lifted. The survey findings revealed that in the future, physical and online-to-offline integrated fairs could complement each other. (Key survey findings are shown in the appendix below.)EXHIBITION+ reinvents trade fairs to serve businesses anytime, anywhereEXHIBITION+ comprises four key exhibition elements, including HKTDC-organised physical fairs, the smart business-matching platform Click2Match, online-to-offline seminars under the Intelligence Hub, and the hktdc.com Sourcing platform, to provide round-the-clock services that boost the flexibility and effectiveness of business promotion for SMEs and offer benefits such as extended fair periods, expanded platforms and enhanced opportunities. EXHIBITION+ extends face-to-face interactions from physical exhibitions to an online smart business-matching platform to help enterprises connect with business partners proactively. As always, the HKTDC's 50 global offices will actively recruit international buyers, while its business-matching specialists will match suitable exhibitors according to buyers' sourcing demands, and arrange online and offline meetings to facilitate business cooperation.Experience a unique business journeyWith EXHIBITION+, exhibitors can start displaying their products to buyers on the fair website one month before the physical fair, while buyers can browse for products and shortlist exhibitors. One week before the physical fair, both buyers and exhibitors can actively search for business targets through the Click2Match platform, check out AI-recommended leads and send meeting requests. During the physical fair, they can meet at the fairground or online via Click2Match, while further online meetings can be scheduled and conducted up to one week after the fair. Exhibitors can still receive sourcing enquiries from buyers up to one month after the fair.Click2Match connects suppliers with global buyers in a clickSmart business-matching platform Click2Match is built on the HKTDC's extensive database to greatly enhance the accuracy of smart matching through AI and big data analytics. Compared to physical exhibitions, where exhibitors typically need to wait for buyers to visit their booths, Click2Match enables them to actively search for suitable buyers and arrange meetings with global buyers. The platform features meeting scheduling, video conferencing, instant messaging, message translation (up to 14 languages), and file-sharing functions to facilitate easy communication between buyers and suppliers.Fair attendees need just one account to seamlessly connect to the various HKTDC online platforms, allowing them to navigate between fair websites, Click2Match, hktdc.com Sourcing and the HKTDC Marketplace App anytime and anywhere. In addition, a series of online and offline seminars and conferences will be hosted during exhibition periods, helping attendees tap into the latest market trends by attending activities in person or watching via livestreaming or playback.Some exhibitors were given prior access to use the Click2Match platform in March. One of the exhibitors, Zuri Jewelry Company Ltd Director Victor Yiu, said the platform is very user-friendly. "We can even check buyers' information before the fair and understand their sourcing demands, allowing us to better prepare for meetings and select the right products for buyers," Mr Yiu said. Another exhibitor, Chit Tat Clock & Watch Co Ltd General Manager Philip Lau, said he is using Click2Match to actively search for overseas buyers. "We will keep track of AI-recommended leads, look at their sourcing demands and schedule meetings in advance, hoping to increase the chance of orders being placed."hktdc.com Sourcing helps explore blue ocean opportunitiesAs an extension of the physical fairs, hktdc.com Sourcing provides a trusted year-round online promotional platform. In addition to connecting with buyers at physical fairs, exhibitors can also seek out potential buyers in unexplored blue ocean markets, such as those specialising in online sourcing and overseas buyers that are unable to visit fairs. The platform shows exhibitors' profiles, along with a comprehensive overview of their products and services, increasing their exposure to buyers. The HKTDC recently added a "Request for Quotation" (RFQ) service to the platform, collecting sourcing requests from quality and reliable buyers and helping suppliers to seize every opportunity.Comprehensive support to help SMEs' transformationTo comprehensively facilitate SMEs to upgrade and transform their business, and to help them maintain their competitiveness, the HKTDC offers a series of platforms and services, including the Digital Academy and E-Tailing Academy, providing professional training related to e-commerce and digital business. The Council also collaborates with major technological enterprises to provide cost-effective e-commerce, digital marketing and enterprise resources planning for SMEs.T-box helps SMEs create business opportunitiesTransformation Sandbox (T-box) is a three-month programme initiated by the HKTDC to promote SMEs' business upgrading and transformation, catering to their needs in the areas of branding, e-commerce, manufacturing and supply chain solutions and exploring new markets. The programme provides advisory services, workshops and government-funding information, helping enterprises to navigate trends, enhance techniques and expand their business network. T-box has attracted more than 2,000 SMEs to join since its launch. The HKTDC will step up its efforts to assist Hong Kong's SMEs in further developing overseas markets through a series of activities. These include liaising with Hong Kong business associations around the world and providing training, group consultations and exchanges with trade committees from foreign chambers of commerce or consulates to join HKTDC's overseas events, helping to build commercial connections and arrange business matching.The HKTDC also strives to support SMEs in exploring business opportunities in other mature or new markets, including continuous support for Hong Kong companies in developing business in the ASEAN bloc and reinforcing the HKTDC's flagship overseas promotional events. For example, the "Think Business, Think Hong Kong" event will be enhanced with online-to-offline promotional platforms, offering a continuous business matching service along with an SME support scheme and various training activities, helping Hong Kong companies to connect with global enterprises and seize business opportunities in a more effective way.Physical International Sourcing Show runs in parallel with online Click2MatchThe upcoming HKTDC International Sourcing Show brings together seven trade fairs, including the HKTDC Hong Kong Electronic Fair (Spring Edition), HKTDC Hong Kong International Lighting Fair (Spring Edition), HKTDC Hong Kong Gifts & Premium Fair, Hong Kong Houseware Fair, HKTDC Hong Kong Fashion Week, HKTDC Hong Kong International Home Textiles & Furnishing Fair, and the Hong Kong International Printing & Packaging Fair, attracting over 1,700 exhibitors from 12 countries and regions with more than 83,000 products. The physical edition will be held from 5 to 8 July in the format of display showcases. Exhibitors and buyers who cannot join due to international travel restrictions can stay connected through Click2Match, the smart business-matching platform of EXHIBITION+, from 5 to 15 July.Four themed categories display a variety of productsThemed "Smarter Sourcing - Better Living", the International Sourcing Show will highlight a broad range of quality lifestyle products under four main categories, namely Healthy Living, Smart Living, Stylish Living and Sustainable Living. Highlighted products include the TiO2 table lamp, which features 24/7 antibacterial, antivirus, and air purification functions; smart cycling glasses that combine micro-lens, micro-display and thin-film encapsulation Internet of Things (IoT) technologies; and a wireless "lapstation" bag combining wireless charging and workstation, with heat ventilation and water-resistant design.Seminars share marketing strategies and innovative technology applicationsA host of seminars will be held during the show covering hot topics such as digital and social media marketing strategies, testing and qualification services for textiles and shoe production supply chains, the aesthetics of scientific design research, IoT innovation beyond the home, and an introduction to the government's Dedicated Fund on Branding, Upgrading and Domestic Sales (BUD Fund). There will also be networking sessions, assisting enterprises to stay connected and expand business opportunities.Main survey findings from "B2B Online Sourcing: A Buyer Behaviour Study Towards Recovery"Buyers who used online sourcing platforms in the past 12 months- Yes 93%- No 7%Buyers who joined virtual fairs in the past 12 months- Yes 85.5%- No 14.5%Buyers' sourcing preferences in post-COVID-19 era- Physical fairs 63%- Hybrid fairs 59%- Virtual fairs 37%- Online sourcing platforms 21%2022 International Sourcing Show DetailsDate and time (physical fair): 5-7 July (Tue to Thu) 10am-6pm, 8 July (Fri) 10am-5pmOpening period for Click2Match platform: 5-15 JulyVenue (physical fair): Hall 1C, Hong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan Chai, Hong KongExhibition covered: - Hong Kong Electronics Fair (Spring Edition)- Hong Kong International Lighting Fair (Spring Edition)- Hong Kong Gifts & Premium Fair- Hong Kong Houseware Fair- Hong Kong Fashion Week- Hong Kong International Home Textiles and Furnishings Fair- Hong Kong International Printing & Packaging Fair (co-organised with CIEC Exhibition Company [HK) Limited)International Sourcing Show website: https://isshow.hktdc.com/Related website- hktdc.com Sourcing: https://sourcing.hktdc.com/- HKTDC Media Room: http://mediaroom.hktdc.com/- Photo download: https://bit.ly/3HYyQUNAbout HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedInMedia enquiriesPlease contact the HKTDC's Communications & Public Affairs Department:Clayton Lauw, Tel: +852 2584 4472, Email: clayton.y.lauw@hktdc.orgAgnes Wat, Tel: +852 2584 4554, Email: agnes.ky.wat@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

国轩高科拟在欧洲投建年产18GWh生产基地

28 6 月, 2022
HONG KONG, Jun 28, 2022 - (亚太商讯 via SEAPRWire.com) - 6月27日，国轩高科在德国哥廷根工厂举行了第五届新能源经济论坛暨德国国轩开幕仪式。据悉，哥廷根基地作为国轩在欧洲的首个电池生产运营基地，预计今年底启动改造。董事长李缜表示，国轩将中国先进的电池技术与德国先进的工艺工程完美地结合，正式开启国轩电池“欧洲造”步伐。当天的仪式上，国轩高科还发布了其首款面向海外市场的便携储能产品品牌GenDome及首款便携移动储能产品Gendock 3000。中国驻德国特命全权大使吴恳，德国下萨克森州州长斯蒂芬‧魏尔，安徽省委常委、常务副省长刘惠、哥廷根市市长佩特拉‧布鲁伊斯特、合肥市人民政府市长罗云峰等中德政要与国轩高科董事长李缜共同参与并见证。哥廷根基地首期6GWh预计今年底启动改造据悉，哥廷根基地基地占地面积约17.4万平方米，现有建筑面积约4万平方米。根据规划，该项目分棕地工厂和绿地工厂两期建设，年产目标分别为6GWh和12GWh，其中第一期棕地工厂改造建设预计2022年底正式启动，2023年9月实现第一条产线3.5GWh的正式投产。基地棕地和绿地工厂完全投产后预计可实现年产18GWh的产能目标。国轩哥廷根工厂厂长 Ahmet Toptas博士介绍：哥廷根基地会以产品为导向，以实现碳中和为终极目标，打造欧洲本土化的产品研发团队，结合欧洲新能源市场发展与技术导向，研发符合欧洲本土的新能源电池产品，开展大巴电池、汽车电池、储能电池、移动充电等系列产品的生产，未来客户拟覆盖储能、商用车及乘用车领域。“国轩高科先进的磷酸铁锂电芯技术，加上经验丰富的德国员工，严格的质量管控和欧洲高标准的品质要求，未来客户拟覆盖储能、商用车及乘用车领域，满足欧洲新能源市场的需求，助力国轩高科加速开拓海外市场。”首款海外便携储能产品将在哥廷根本地化制造继国轩高科5月份发布了半固态电池和首款智能移动储能充电桩之后，国轩高科的电池产品家族再添新成员。开幕仪式当天，哥廷根基地发布了首个面向海外市场的便携储能产品品牌GenDome，及其首款大容量便携移动储能产品Gendock 3000，可将太阳能和风能转化为电能；可帮助客户管理家庭能源使用，满足日常家庭和户外使用需求，能够满足客户99%的电力需求，有效减少能源支付账单。该款家用储能产品有三种不同型号，由国轩高科的国际业务团队研发及制造，未来主要面向欧洲市场，后期该产品将在哥廷根基地实现本地化制造。开幕仪式当天，由国轩高科、百人会(Committee of 100)、布伦瑞克大学(Technical University of Braunschweig)、哥廷根经济促进与城市发展协会(GWG)和德国中国商会(Die Chinesische Handelskammer in Deutschland, CHKD)、同济大学汽车学院等联合举办的第五届新能源经济论坛也在哥廷根工厂顺利召开。论坛围绕中欧经济关系、能源革命、低碳化、新能源市场等话题进行讨论，吸引了新能源产业多家名企高管，大学教授学者及相关经济政要参加。国轩高科董事长李缜: 中国技术加德国工艺，国轩电池开启“欧洲造”国轩高科国际业务总裁李晨在闭幕致辞中介绍，国轩高科是一家全球化公司，为海内外供应商、客户等其他合作伙伴提供能源解决方案。“我们不仅聚焦新能源电池产品开发和推广，同步也致力于开拓TC业务。”李晨表示，2022年5月至今，国轩陆续发布国轩自主研发的首款面向普通消费者的易佳电智能移动储能充电桩产品和面向海外市场的Gendome便携储能产品。2025年国轩高科全球产能规划将达到300GWh，其中海外产能规划100GWh。国轩高科董事长李缜在致辞中表示，今天我们在这里开启国轩电池在德国乃至欧洲的应用研发和产品制造。国轩的哥廷根工厂，将逐步从过去的生产汽车零部件，转变成制造电池应用产品，这是一个艰难但充满希望的历程。在此过程中一要保护好已有的企业文化，二要积极参与哥廷根的城市发展，三要加快产品转型的步伐。“我们一定将中国先进的电池技术，德国先进的工艺工程，完美地结合起来，创造更加美善的产品，贡献给社会，以推动新能源产业的进步与发展。” Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

兴业银行举办第一期乡村振兴大课堂

28 6 月, 2022
HONG KONG, Jun 28, 2022 - (亚太商讯 via SEAPRWire.com) - 6月23日至25日，兴业银行第一期乡村振兴大课堂在中共兴业银行党校举行，来自尤溪县40多名县直机关和乡镇主要负责人参加了培训。此次培训课程包括专题讲座、现场教学、交流研讨等环节。本次乡村振兴大课堂专门邀请了厦门大学朱冬亮教授前来授课，他从事乡村发展与乡村振兴等专题研究多年。课堂上，他围绕乡村振兴战略实施的时代背景和政策设计、当前乡村振兴战略实施的主要目标和建设路径等内容深入讲解，让学员们耳目一新，更加深入了解乡村振兴的重大历史意义与发展机遇。兴业银行普惠金融部（乡村振兴部）工作人员围绕该行打造特色乡村振兴模式，推动福建省乡村产业发展等情况进行了系统介绍，让学员们进一步了解到该行各项服务乡村振兴的金融政策。培训期间，学员们还一同前往福建省乡村振兴示范村厦门市同安区大同街道田洋村参观，深入了解田洋村依托“文旅经济”打造美丽乡村，以文化旅游促进乡村振兴的生动实践。尤溪县是兴业银行乡村振兴挂钩帮扶县，乡村振兴大课堂是该行加快打造尤溪乡村振兴样板工作的又一举措。通过本次培训，提升了基层乡镇干部的乡村振兴理论水平，加深了对金融服务乡村振兴的理解。兴业银行将结合尤溪县委县政府提出的“3+2+2”产业发展新格局及“1366”特色现代农业提升工程，从产业帮扶、科技帮扶、渠道帮扶、公益帮扶等方面多方发力，助力尤溪县产业高质高效、乡村宜居宜业、农民富裕富足。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Dah Sing Bank and Friends of the Earth (HK) Jointly Present Property and Construction Industry ESG Forum for SMEs ACN Newswire

Dah Sing Bank and Friends of the Earth (HK) Jointly Present Property and Construction Industry ESG Forum for SMEs

27 6 月, 2022
HONG KONG, Jun 27, 2022 - (ACN Newswire via SEAPRWire.com) - The first industry forum ("the Forum") under the "SME ESG Best Practices Recognition Programme" ("the Programme") took place today under the joint auspices of Dah Sing Bank, Limited ("Dah Sing Bank") and Friends of the Earth (HK) ("FoE HK"). Held in the theme of "ESG Practices in Property Development Supply Chain - Opportunities and Challenges for SMEs", the Forum featured listed company senior executives and leaders in the property and construction sector to share their insights on the impact environmental, social and governance (ESG) trends have on the outlook and operating models related to their industries.Dah Sing Bank and Friends of the Earth (HK) Jointly Present: The SME ESG Best Practices Recognition Programme"ESG Practices in Property Development Supply Chain - Opportunities and Challenges to SMEs" Guest ListMs. Mei Ng, BBS, Chairperson, Friends of the Earth (HK) delivering speechMs. Phoebe Wong, Deputy Chief Executive, Senior Executive Director, Group Head of Personal Banking, Dah Sing Bank delivering speechMs. Phoebe Wong, Deputy Chief Executive, Senior Executive Director, Group Head of Personal Banking, Dah Sing Bank (Right) Ms. Mei Ng, BBS, Chairperson, Friends of the Earth (HK) (Left)The Forum - Topic 1The Forum - Topic 2Addressing the Forum, Mrs Mei Ng, BBS, Chairperson of FoE HK, said, "SMEs are closely intertwined in every aspect of our daily lives. Notwithstanding their contribution to our society, economy and livelihoods, they also impact on our ecological environment, social development and daily production in a big way. FoE HK believes there is a critical and urgent need to help local SMEs transform, upgrade, strengthen and enhance their competitiveness as well as their ESG accountability. ESG can help SMEs come to grips with matters concerning their survival, risks, transformation, potential and opportunities, helping them to achieve profitability without polluting the world, run their business worry-free while winning word of mouth, customers and investors, and a bright future."ESG implementation may become one of the ways for SMEs to overcome adversity in a down market. The convergence of external economic pressures and the pandemic is presenting unprecedented challenges for SMEs. With the rise of a green economy, corporations are becoming more demanding in their partnership and supply chain governance standards and requirements. For listed companies, ESG implementation is not just to meet regulatory requirements, but also to help enhance the sustainability of their supply chains. As such, SMEs stand to gain from reviewing their existing operating models for alignment with global sustainable development strategies. The integration of an ESG mindset into their business operations and decisions will enable their products, services and brand image to stand out, thereby helping them enhance their competitiveness and resilience.Through the sharing of insights from industry leaders, the two-part Forum seeks to help SMEs understand the latest ESG trends and the opportunities that may arise through ESG implementation, thereby encourage them to develop sustainable business strategies. Moderated by Ms. Athena Ng, General Manager, Corporate Finance and Corporate Communications of China Overseas Land and Investment & Board Governor and Honorary Treasurer of Friends of the Earth (HK), the first part of the Forum focused on the relevance of ESG to the real estate development supply chain and how to seek win-win with SMEs through collaboration in ESG implementation. The second part of the Forum explored the directions and approaches of ESG implementation; moderated by Ms. Ophelia Lin, Founding President of SME Sustainability Society & Board Governor of Friends of the Earth (HK), the guest speakers suggested ways for SMEs to embark on their ESG journey to enhance the competitiveness of their businesses.The team of professionals behind the Programme can be described as "ESG doctors" for enterprise development. Consultancies offering such services are a commonplace practice in the market and typically command fees of more than HKD100,000. SMEs taking part in the Programme will have free access to similar support, so that they may be able to identify areas for improvement in their businesses as early as possible and to plan ahead.Ms. Phoebe Wong, Deputy Chief Executive, Senior Executive Director, Group Head of Personal Banking of Dah Sing Bank, said, "SMEs typically lack ESG-related knowledge and resources. Dah Sing Bank is sponsoring FoE HK to launch this Programme so that more SMEs will become aware of the most pressing ESG issues that concern them, and enable them to identify improvement areas through the Programme's free assessment and ESG guidelines. Last year, the Hong Kong Government announced its target to achieve carbon neutrality by 2050. As buildings are the main source of carbon emissions in the city, it is pertinent to feature the property and construction sector in the first forum under the Programme. This will create awareness of the urgency for the sector's SMEs to transition to a low-carbon operating model, and will bring new ideas and opportunities to inspire them to embark on adopting sustainable business practices."The Programme is the first of its kind that takes on an industry-specific approach to lobby and recognise ESG best practices adoption by SMEs and to promote sustainable development in industries. Using the United Nations Sustainable Development Goals as framework, it evaluates the sustainable development strategies and policies of SMEs and their ability to manage and drive sustainable development performance. SMEs that attain a certain level of improvement within a specific period will be commended for their commitment and contribution. The free-to-join Programme is sponsored by Dah Sing Bank. Additionally, Dah Sing Bank is offering further incentives to all the SMEs participating in the Programme and / or receiving recognition in the form of fee discounts and cash rebates, while recognised participants will also receive an exclusive HKD1,000 cash reward. SMEs in the property and construction industries can enroll in the Programme starting today (27 June) until 31 August 2022. Please refer to the attached fact sheet for details.This year marks the 75th anniversary of Dah Sing Bank. A series of celebratory activities will be launched from June onwards to reach out to the community, SMEs and customers as well as to promote green lifestyles. Through these activities, the Bank hopes to thank and share its joy with the public and its customers, express its advocacy for sustainable lifestyles, and bring vitality to Hong Kong's communities and economy. For details, please visit the Bank's 75th anniversary webpage on http://www.dahsing.com/75Anniv/en.About Dah Sing BankDah Sing Bank, Limited ("Dah Sing Bank") is a wholly-owned subsidiary of Dah Sing Banking Group Limited (HKG:2356) which is listed on the Hong Kong Stock Exchange. Founded in Hong Kong 75 years ago, Dah Sing Bank has been providing quality banking products and services to our customers with a vision to be "The Local Bank with a Personal Touch". Over the years, Dah Sing Bank has been rigorous in delivering on our brand promise to grow with our customers in Hong Kong, the Greater Bay Area and beyond - "Together We Progress and Prosper". Building on our experience and solid foundation in the industry, Dah Sing Bank's scope of professional services now spans retail banking, private banking, business and commercial banking. Meanwhile, Dah Sing Bank is also making significant investments in our digital banking capabilities to stay abreast with smart banking developments in Hong Kong and to support financial inclusion at large.In addition to its Hong Kong banking operations, Dah Sing Bank also has wholly-owned subsidiaries including Dah Sing Bank (China) Limited, Banco Comercial de Macau, S.A., and OK Finance Limited. It is also a strategic shareholder of Bank of Chongqing with a shareholding of about 13%. Dah Sing Bank and its subsidiaries now have around 70 operating locations in Hong Kong, Macau and Mainland China.About Friends of the Earth (HK)Friends of the Earth (HK), as a leading environmental advocate, focuses on protecting our local and regional environment, offers equitable solutions to help create environmentally sustainable public policies, business practices and community lifestyles and engages government, business and community to act responsibly. Friends of the Earth (HK) is dedicated to promote green finance and cultivate ESG talents to transition HK and Asia Pacific region into a carbon neutral economy. Friends of the Earth (HK) closely partners with SME associations in Hong Kong (with coverage >3,000 companies), as well as international associations (e.g., World Benchmarking Alliance), with strong access to ESG & green finance talents professionals in Hong Kong, through our CESGA alumni network. Friends of the Earth (HK) launched the first Green Finance Roadmap of its kind in the APAC region in 2019. One of our key focus would be on building capacity for industry practitioners and general public towards green finance, and hence our events are centered around "Green Finance Connect Education Series". Examples include Sustainability Leadership Seminars, our Green Finance Symposium on ESG integration. We aim to work with all sectors of the community to build a sustainable society and environment.Media EnquiriesDah Sing Bank, LimitedGigi Lee +852 2507 8629 gigiwclee@dahsing.com Friends of the Earth (HK)Tiffany Yip +852 3184 1510 tiffanyyip@foe.org.hk Strategic Financial Relations LimitedMargaret Lam +852 2114 4956 margaret.lam@sprg.com.hkPinky Hui +852 2114 2897 pinky.hui@sprg.com.hkCynthia Ng +852 2114 4952 cynthia.ng@sprg.com.hk Programme websitehttps://bit.ly/3HJDgPj Dah Sing Bank offers exclusive Programme Incentiveshttps://bit.ly/3OncS0l Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

玄武云招股中：国内最大智慧CRM服务供应商 核心客户净收入留存率超100%

27 6 月, 2022
HONG KONG, Jun 27, 2022 - (亚太商讯 via SEAPRWire.com) - 据香港经济日报报道，大数据时代，数字化浪潮席卷而来，智慧CRM集云和全触点通信、人工智能和数据智能等功能为一体，提供PaaS和SaaS服务，使客户能够以更高效和有效的方式管理其整个业务周期。随着企业数字化转型需求成为行业趋势，管理企业关键运营的智慧CRM服务正快速取代传统CRM服务，成为企业的新选择。成立于2010年的玄武云科技控股有限公司（「玄武云」，股份代号：2392.HK）是智慧CRM服务行业的领导者，专注于为用户提供综合智慧CRM服务，覆盖用户全渠道及全生命周期，为企业效率增长以及收入提升注入新动力。6月24日，玄武云开启港股招股，最高发售价为每股6.91港元，距香港上市仅一步之遥。智慧CRM服务行业龙头 服务涵盖客户全生命周期玄武云向客户提供CRM PaaS及CRM SaaS服务，凭藉云和全触点通信、人工智能及数据智能能力，为客户提供综合智慧CRM服务，覆盖客户全渠道及全生命周期，助力其业务获得成功。和大部分CRM公司专注于某个领域或某个服务，通过生态融入行业云不同，玄武云研发的aPaaS平台，可针对不同行业场景提供个性化开发服务，为客户提供覆盖全渠道、全生命周期的产品及服务。按2021年的国内智慧CRM服务供应商收益计，玄武云是中国国内最大的智慧CRM服务供应商。长期以来，玄武云积累了多个高增长行业的头部客户群。于2021年，玄武云智慧CRM服务覆盖食品及饮料分部百强企业中的28家及24家、日用品及白酒分部百强企业中的20家及10家、银行分部百强企业中的37家、138家受监管证券公司中的30家、互联网及软件分部百强企业中的21家及15家。根据弗若斯特沙利文报告，在金融、TMT及政企行业，按中国智慧CRM服务行业2020年的收益计，玄武云分别排名第一、第一及第三。在为客户提供智慧CRM服务的过程中，玄武云积累了丰富的行业经验以及专业知识，同时覆盖全生命周期的服务模式使其能够很好地适应市场动态变化，满足客户不断增长的CRM需求，形成较好的客户粘性。2019-2021三个年度，该公司核心客户的年度净收入留存率从2019年的99.9% 升至2021年的102.2%。无论是从市场份额、客户合作还是产品复购数据来看，玄武云综合竞争力均处于行业领先地位。行业极具增长潜力 有望迎来加速释放从行业发展来看，随着智慧CRM服务的数字化转型及越来越高的市场接受程度，更多的企业将采用智慧CRM服务。根据弗若斯特沙利文报告，中国智慧CRM服务市场的TAM预计将由2021年的人民币718亿元增长至2026年的人民币2,800亿元，复合年增长率约为31.3%。智慧CRM服务市场的总收益预计将由2021年的人民币72亿元增长至2026年的人民币368亿元，复合年增长率高达38.6%。玄武云在多个行业领域深耕多年，高度可扩展的业务模式可以支持公司以较低的边际成本扩展各个行业内的中小型企业，从而实现更高的经济效应。同时，多元化的服务组合也为公司制造出交叉销售机会，贡献更多收益。在强大云基础架构支持下，公司的综合智慧CRM服务能够满足客户业务拓展过程中逐步增加的CRM需求，并将受益于中国智慧CRM服务行业需求的强劲增长。业绩方面，玄武云于过去几年实现了显着增长。2018年至2021年，收益分别约人民币5.19亿元、6.00亿元、7.97亿元、9.92亿元，复合年增长率为24.1%。展望未来，智慧CRM服务行业增长潜力十足，本次IPO后，玄武云的品牌实力和资本实力将进一步增强，业务成长有望加速释放。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
EC Healthcare Received “Institutional Investor” 2022 Multiple Awards in All-Asia Executive Team Rankings ACN Newswire

EC Healthcare Received “Institutional Investor” 2022 Multiple Awards in All-Asia Executive Team Rankings

27 6 月, 2022
HONG KONG, Jun 27, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the excellent result in the "All-Asia Executive Team Rankings 2022" under the category of Healthcare & Pharmaceutical organized by Institutional Investor, an international magazine. The Group is delighted recognize as The Most Honoured Company (Healthcare & Pharmaceutical) in the division - Asia (excluding mainland China), which represents recognition of the Group's impressive performance by the investors and the market. Recognized as an authoritative ranking by industries, "All-Asia Executive Team Rankings" celebrates the outstanding companies and management teams in Asia. Buy-side and sell-side analysts rated the listed companies within the scope of their research according to several criteria used in evaluating performance in corporate governance.Category / AwardCore Asia Results / Best IR TeamAsia ex-Mainland China:The Most Honoured CompanyBest CEO - Mr. Eddy TangBest CFO - Mr. Levin LeeBest Investor Relations Program Best ESGBest Investor Relations Professional - Mr. Christopher Wong / Ms. Hermione HeAsia Small and Midcap:Best CEO - Mr. Eddy TangBest CFO - Mr. Levin LeeBest Investor Relations Program Best ESGBest Investor Relations Professional - Mr. Christopher WongMr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "The Group is honoured and grateful to receive these awards. We will continue to spare tremendous effort with the aim of further consolidating the leading position in the healthcare market and maximizing our shareholder value. The Group wishes to excel together with our much-valued stakeholders and stay proactive in continuously refining our strategies for the overall welfare of our company and the greater community."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, a advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

中播︰智能城市、车联网驱动的航天科技年代受益者

27 6 月, 2022
HONG KONG, Jun 27, 2022 - (亚太商讯 via SEAPRWire.com) - 虽然受到疫情持续的影响，但不少发达及新兴国家并没有因此减少在科技领域的投资，反而在疫情下更深深体会到科技的巨大动能是提升国家抗逆力的关键。根据IDC发布的《全球智能城市支出指南》(IDC Worldwide Smart Cities Spending Guide, 2020V1)，全球智能城市相关支出规模的增速虽因新冠疫情的影响而放缓，但预计中长期将恢复并保持15%以上的增长态势。2020年，全球智慧城市市场相关投资总额达到1,144亿美元，同比增长11.1%，但低于2019年12月发布的18.9%增长预测。不过，IDC 预计，全球智慧城市支出将在2020-2024年的预测期间内实现14.6%的复合年增长率(CAGR)。换言之，2022年至2024年的全球智慧城市支出或有望超过16%。至2020年，中国市场支出规模已达到259亿美元，较2019年同比增长12.7%，高于全球平均水平，为仅次于美国的第二大智能城市项目投资国家。据了解，中国市场的三大热点投资项目依次为可持续基础设施、数据驱动治理以及数字化管理。在2020-2024年的预测期间内，三者支出总额将持续超出整体智慧城市投资的一半。智慧城市的建设和发展为新兴技术提供了大量的应用场景，这为技术供货商带来了极大的发展空间。至2020年，中国市场支出金额占比前三的应用场景依次为智能电网(Smart Grids)、固定智慧视频安防(Fixed Video Camera)、联网后台系统(Connected Back Office)，三个应用场景的投资规模占比超过支出总额的40%。随着市场愈发成熟，这三项主流应用场景的支出占比会有所降低。与此同时，智慧城市相关技术的发展，用例呈现多样化趋势，增长迅速的新场景的影响力将会逐渐扩大。IDC预计，在2020-2024年的预测期间内，增长最快的应用场景依次为开放数据(Open Data)、数字孪生(Digital Twin)、下一代紧急事件PSAP(Next-Gen Emergency PSAPs)。巨大的智能城市建设驱动航天信息卫星市场的爆发基于智能城市建设的投资规模巨大，应用场景多元化，对数据传输能力的需求尤其庞大，因此6G网络基建将成为关键设施。而6G网络的组成，主要包括了5G地面网络及航天卫星。5G地面网络固然投资庞大，但航天卫星的建设对6G网络的构建将更为关键。这亦是SpaceX等新兴卫星公司日益成为全球投资者的竉儿的原因。航天卫星分为低轨卫星、中轨卫星及同步轨位卫星(高轨卫星)。前者距离地球大约2,000公里，而高轨卫星则在地球3.6万公里以外。工研院(IEK)产科国际所指出，2020年共有3,372颗人造卫星围绕在地球外，麦肯锡(Mckinsey)预测在最理想的产业发展情况下，2030年将有「5万颗」卫星在太空。其中，接近77%的航天卫星将为低轨卫星。正因如此，全球低轨卫星的设计、制造及发射市场将迎来巨大的发展空间。不过，论价值，高轨卫星因具有稀缺性及广泛地球覆盖面，将具有极大的升值潜力。在中港股市中，唯一拥有高轨卫星 – 亚洲之星资产的上市公司中播(471.HK)，近日宣布分别与三家英美公司 Novocomms Limited、Xingtera Inc 及 Vivipari Technology Limited 共同签署了一份谅解备忘录，组建合资公司，以汇聚各方资源，强化和伸延中播正持续开发的卫星-5G 数据传输平台至智能城市服务应用场景，提供全方位物联网及车联网解决方案及项目经营，面向中国和东盟地区政府和企业客户，为城市增强数字基础设施、无线和移动网络的无缝覆盖和媒体信息传输，从而全面促进城市的管理效率、公共信息传播、提升政府服务质量和公民便利，令到环境、社会、经济和投资方面变得更「智能」和有效益。 新一代卫星互联网「数据即服务」运营商据了解，中播的三家企业伙伴分别来自英美两地。Novocomms Limited位于英国曼彻斯特，专门从事新型高端无线电天线的技术设计和开发，包括毫米级的电波频率波，并拥有世界其中最领先的移动卫星通信和太赫兹(Terahertz)传感器技术。Xingtera Inc. 则位于美国加州硅谷，专门从事物联网产品应用、解决方案和系统开发，集成和运营，并且是美国高通公司特别指定的系统和解决方案集成商与战略伙伴，通过高通的「智能城市加速器程序」提供全方位智能城市解决方案，Xingtera也是高通科技生态系统的关键 5G PN 合作伙伴。英国公司Vivipari Technology Limited专门从事无线通信服务，为企业提供基于 5G / LTE / Wi-Fi 和卫星的无线接受解决方案，并且是 NVC 在亚洲专门指定的天线产品和技术分销商。合资公司成立后，将汇聚各方技术、资源及能力，涵盖卫星移动数据广播、通信、5G、遥感探测监控、人工智能、大数据分析、数字多媒体运营、物联网系统集成及项目管理等领域，具雄厚的实力为亚洲区域和地方政府提供全方位、综合性智能城市数字化解决方案和项目管理，以铺垫无处不在、全民普及、成本低廉的数字化基础设施和服务平台，包括数字媒体娱乐、公共信息传播、应急广播、智能交通和物流管理，及智能车联网相关的信息娱乐。 预期随着合资公司的成立，中播将大幅度提升其在应用整合、服务运营、市场开发的综合力量，使平台优势伸延及复制至多个智能城市新应用场景，助力其成为新一代卫星互联网「数据即服务」运营商，料将大大提升中播的盈利前景。同时，中播亦已计划进行一系列并购，为后续的平台入市做好部署。公司目前已完成收购注入「亚洲之星」卫星服务平台系统，结合公司已有的卫星-5G 融合传输技术，以及人工智能和大数据技术方案平台，将打造其成为亚洲最大智能移动数据分发网络商，以全覆盖，大容量和免用户流量资费的优势，为亚洲区(包括中国和东盟)新能源智能车提供多元化、全天候和低消费的车联网信息娱乐和数据服务。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
32nd annual Hong Kong Book Fair returns on 20 July ACN Newswire

32nd annual Hong Kong Book Fair returns on 20 July

24 6 月, 2022
HONG KONG, Jun 24, 2022 - (ACN Newswire via SEAPRWire.com) - The 32nd HKTDC Hong Kong Book Fair, organised by the Hong Kong Trade Development Council (HKTDC), will run from 20 to 26 July (Wednesday to Tuesday) at the Hong Kong Convention and Exhibition Centre (HKCEC). Tickets will open for sale on 27 June while online registration for seminars opens today (24 June), offering a wide range of stimulating and thought-provoking events for Hong Kong's booklovers.The 32nd annual HKTDC Hong Kong Book Fair returns on 20 July. The theme of this year's fair is "History and City Literature", with the tagline "Reading the World: Stories of Hong Kong". The HKTDC will introduce celebrated authors and their outstanding works to Hong Kong's booklovers, sharing the joy of reading with the public. The picture shows scenes from last year's Book Fair.As one of the celebration events for the 25th anniversary of the establishment of the Hong Kong Special Administrative Region, the HKTDC has invited renowned authors to host and participate in seminars and cultural events. The Book Fair will run in parallel with the 5th HKTDC Hong Kong Sports and Leisure Expo and 2nd HKTDC World of Snacks, giving visitors the chance to enjoy three very different experiences with a single ticket.Theme of the year: "History and City Literature"The theme of this year's Book Fair is "History and City Literature", with the tagline "Reading the World: Stories of Hong Kong". The HKTDC will introduce celebrated authors and their outstanding works to booklovers, giving them a deeper understanding of Hong Kong's historical and cultural development and promoting the joy of reading among the public. Thematic exhibitions titled "History Writers" and "City Literature" will be featured at the Art Gallery, allowing visitors to savour Hong Kong's unique story through literature and arts. Two other exhibitions, "Tastes of Hong Kong" and "Hong Kong Architecture", will offer different perspectives on the city's lifestyle and culture through collections and artworks.The "Eight Seminar Series" is one of the highlights at the Book Fair. This year's topics include "Stories of Hong Kong", "Renowned Writers", "English and International Reading", "World of Knowledge", "Children and Youth Reading", "Lifestyle", "Hong Kong Cultural and Historical", and "Personal Development and Spiritual Growth". Meanwhile, the always popular "Storytelling by Celebrities" series will invite star speakers to share inspirational stories with children.Diverse experiences at Sports and Leisure Expo and World of SnacksThis year's Hong Kong Sports and Leisure Expo will cover eight thematic zones and bring together a wide range of sports and leisure brands, products and experiences, along with a number of free trials for visitors to enjoy. World of Snacks, meanwhile, features six thematic zones and will offer more than 1,000 tasty treats from across the globe, including Japan, Taiwan, South Korea, Germany, Australia, Greece and Spain.Online registration for the Book Fair's seminars opens today and is free of charge on a first-come-first-served basis. Please visit www.hkbookfair.com to reserve a spot. Tickets for the fair will open for sale on 27 June - find more details in the appendix below.The HKTDC's Cultural Salon Press Conference will be held in early July to provide more information on the Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks. Details of the Art Gallery thematic exhibitions will be provided with the author line-up for the "Eight Seminar Series" and other cultural activities. Featured events and activities from the Hong Kong Sports and Leisure Expo and World of Snacks will also be covered. Meanwhile, the HKTDC Education & Career Expo will run alongside the three events from 21 to 24 July. Details will be announced in due course.Hong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks* See https://mediaroom.hktdc.com/en/pressrelease/detail/20358/Photo Download: https://bit.ly/3QJpmkkAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedInMedia enquiriesHong Kong Book FairHKTDC's Communications & Public Affairs Department:Clementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.orgSunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.orgSam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.orgYuan Tung Financial Relations:Agnes Yiu, Tel: +852 3428 5690, Email: ayiu@yuantung.com.hkHing-Fung Wong, Tel: +852 3428 3122, Email: hfwong@yuantung.com.hkHong Kong Sports and Leisure Expo, World of SnacksHKTDC's Communications & Public Affairs Department:Frankie Leung, Tel: +852 2584 4298, Email: frankie.cy.leung@hktdc.orgYuan Tung Financial Relations:Tiffany Leung, Tel: +852 3428 2361, Email: tleung@yuantung.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
AEON信贷财务2022年第一季度收入增长9.7%至279,100,000港元 ACN Newswire

AEON信贷财务2022年第一季度收入增长9.7%至279,100,000港元

23 6 月, 2022
HONG KONG, Jun 23, 2022 - (亚太商讯 via SEAPRWire.com) - AEON信贷财务（亚洲）有限公司（「AEON信贷财务」或「集团」；股票代号：00900）今天公布其截至2022年5月31日止三个月之未经审核业绩（「2022年第一季度」或「报告期间」）。2022年第一季度，集团收入较去年同期增加9.7%至279,100,000港元，扣除减值亏损前之营运溢利增加16.4%至126,900,000港元。集团于报告期间录得溢利82,700,000港元（2021年第一季度：97,000,000港元）及每股盈利19.74港仙。2022年第一季度整体销售额比2021年第一季度增长12.3%，客户贷款及应收款项总额与2022年2月末的余额相比增加4.0%。随着集团作为信用卡发卡及收单机构以及保险中介机构的销售额增加，征收费用及佣金较去年同期增加7,400,000 港元至28,900,000港元。与此同时，在应收账款余额持续增加之下，利息收入增加15,800,000港元至233,900,000 港元，加上现金预支需求增加带动手续费及逾期收费增加，因而令集团的收入及营运溢利显著增长。然而，尽管收入增长稳健，溢利于报告期间仍减少，归因于报告期间经济复苏预期缓慢，与2021年第一季度主要经济指标回升的预期形成鲜明对比，导致减值亏损及减值准备相对显著增加。 作为迎合新常态下客户转至网上消费及扩大客户基础的策略，集团于2022年5月推出首张现金回赠信用卡AEON Card Wakuwaku（「Wakuwaku卡」），让持卡人于网上及日本海外签账可享特别签账回赠。Wakuwaku卡亦以名人代言推广吸引年轻一代的新客户，获得正面反响，首月发行逾5,000张新卡。随着Wakuwaku卡的营销和品牌建立取得成功，集团将更着重结合数码和传统营销渠道推广信用卡和私人贷款产品，并推出不同的营销计划以丰富客户体验。在技术发展方面，集团目标在本财政年度结束前完成更换信用卡和贷款系统项目，此后集团将推出新的支付方案，更灵活地提供产品优惠及运用更好的数据分析工具。凭借雄厚的资本实力，集团将继续投放资源扩展分行网络、提供更佳客户体验、加快数码化进程及探索新的投资机会，以扩展和多元化发展业务。AEON信贷董事总经理深山友晴先生表示:「尽管2022年第一季度爆发第五波疫情令经营环境充满挑战，但集团乐见收入及营运溢利仍录得增长。集团于期内成功推出Wakuwaku卡，推行策略应对客户消费行为转变，以及吸引年轻一代客户方面均取得良好进展。为满足不断转变的客户需要及把握涌现的市场机遇，我们将继续透过多元化渠道加强营销及推广，同时推行技术升级及加快数码化进程。」关于AEON信贷财务（亚洲）有限公司（股份代号：00900）AEON信贷财务（亚洲）有限公司为AEON Financial Service Co., Ltd.之附属公司（东京证券交易所编号：8570）及AEON集团旗下公司，成立于1987年，并于1995年在香港联合交易所有限公司主板上市。集团主要从事消费融资业务，包括于香港签发信用卡及提供私人贷款融资、信用卡付款处理服务、保险代理及顾问业务，以及于中国内地从事小额融资业务。详情请浏览公司网址：www.aeon.com.hk。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More